FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy - FDA.gov
- FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy FDA.gov
- First Gene Therapy for Muscular Dystrophy Approved The Wall Street Journal
- Sarepta Therapeutics Announces FDA Approval of ELEVIDYS, the First Gene Therapy to Treat Duchenne Muscular Dystrophy Business Wire
- Sarepta's DMD gene therapy secures accelerated FDA approval FiercePharma
- FDA grants conditional approval to Sarepta's gene therapy for Duchenne muscular dystrophy STAT
- View Full Coverage on Google News